期刊
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY
卷 12, 期 1, 页码 -出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.14309/ctg.0000000000000293
关键词
-
资金
- excellence initiative VASCage (Centre for Promoting Vascular Health in the Ageing Community)
- R&D K-Centre (COMET programme-Competence Centers for Excellent Technologies) - Austrian Ministry for Transport, Innovation and Technology
- Austrian Ministry for Digital and Economic Affairs
- federal state Tyrol
- federal state Salzburg
- federal state Vienna
- Austrian Science Fund (FWF) [FP33070-B]
COVID-19 patients show elevated levels of fecal neopterin, especially in those experiencing gastrointestinal symptoms, indicating an inflammatory immune response in the gastrointestinal tract.
INTRODUCTION: Coronavirus disease (COVID-19) has spread from Wuhan, China, and become a worldwide pandemic. Most patients display respiratory symptoms but up to 50% report gastrointestinal symptoms. Neopterin is a surrogate marker for viral inflammation, and its production by macrophages is driven by interferon-gamma. METHODS: We measured fecal neopterin in 37 hospitalized COVID-19 patients not requiring intensive care measures and 22 healthy controls. RESULTS: Fecal neopterin was elevated in stool samples from COVID-19 patients compared with that in samples from healthy controls. Especially, patients reporting gastrointestinal symptoms exhibited increased fecal neopterin values. DISCUSSION: COVID-19 is associated with an inflammatory immune response in the gastrointestinal tract.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据